Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 24 | 2025 | 472 | 4.770 |
Why?
|
| Atherosclerosis | 11 | 2024 | 261 | 2.530 |
Why?
|
| Mechanotransduction, Cellular | 8 | 2024 | 81 | 2.410 |
Why?
|
| Endothelium, Vascular | 15 | 2024 | 433 | 1.680 |
Why?
|
| MicroRNAs | 4 | 2021 | 575 | 1.110 |
Why?
|
| Kruppel-Like Transcription Factors | 5 | 2021 | 104 | 0.920 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 175 | 0.790 |
Why?
|
| Glycolysis | 3 | 2021 | 184 | 0.750 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 6 | 2018 | 122 | 0.730 |
Why?
|
| Lactic Acid | 1 | 2021 | 99 | 0.710 |
Why?
|
| Aorta | 8 | 2022 | 290 | 0.670 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 101 | 0.590 |
Why?
|
| Hemodynamics | 3 | 2018 | 757 | 0.560 |
Why?
|
| Cells, Cultured | 13 | 2021 | 2905 | 0.540 |
Why?
|
| Pulmonary Edema | 1 | 2017 | 53 | 0.540 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 168 | 0.510 |
Why?
|
| Hypercholesterolemia | 6 | 2018 | 161 | 0.490 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2015 | 9 | 0.480 |
Why?
|
| Stress, Mechanical | 5 | 2020 | 256 | 0.460 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 379 | 0.440 |
Why?
|
| Brain Ischemia | 1 | 2018 | 404 | 0.440 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 379 | 0.430 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2025 | 189 | 0.410 |
Why?
|
| Endothelium | 2 | 2025 | 60 | 0.390 |
Why?
|
| Swine | 7 | 2017 | 607 | 0.380 |
Why?
|
| Energy Metabolism | 3 | 2025 | 302 | 0.380 |
Why?
|
| Genetic Variation | 1 | 2018 | 1392 | 0.370 |
Why?
|
| Inflammation | 4 | 2025 | 1024 | 0.350 |
Why?
|
| Arteries | 3 | 2018 | 179 | 0.340 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2023 | 218 | 0.330 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 2007 | 0.330 |
Why?
|
| Animals | 24 | 2025 | 28053 | 0.330 |
Why?
|
| Stroke | 1 | 2018 | 1038 | 0.310 |
Why?
|
| Regional Blood Flow | 4 | 2017 | 198 | 0.310 |
Why?
|
| Gene Expression Profiling | 4 | 2025 | 1480 | 0.300 |
Why?
|
| Humans | 31 | 2025 | 92339 | 0.290 |
Why?
|
| Aortic Diseases | 2 | 2018 | 102 | 0.270 |
Why?
|
| Lipoproteins, LDL | 2 | 2017 | 86 | 0.260 |
Why?
|
| Up-Regulation | 3 | 2021 | 729 | 0.260 |
Why?
|
| Hypoxia | 4 | 2025 | 672 | 0.250 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 741 | 0.250 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 168 | 0.250 |
Why?
|
| Signal Transduction | 7 | 2025 | 3509 | 0.250 |
Why?
|
| Phenotype | 6 | 2021 | 2502 | 0.240 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2025 | 13 | 0.240 |
Why?
|
| Altitude Sickness | 1 | 2025 | 12 | 0.230 |
Why?
|
| Mechanical Phenomena | 2 | 2021 | 15 | 0.230 |
Why?
|
| RNA Interference | 3 | 2018 | 385 | 0.230 |
Why?
|
| Mice, Knockout, ApoE | 2 | 2021 | 8 | 0.230 |
Why?
|
| Cholesterol | 5 | 2018 | 361 | 0.220 |
Why?
|
| Mice | 8 | 2025 | 12136 | 0.220 |
Why?
|
| Micelles | 2 | 2021 | 51 | 0.210 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2023 | 16 | 0.210 |
Why?
|
| Adaptation, Physiological | 2 | 2025 | 324 | 0.210 |
Why?
|
| 3' Untranslated Regions | 2 | 2015 | 96 | 0.210 |
Why?
|
| Myofibroblasts | 1 | 2023 | 50 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1595 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 131 | 0.200 |
Why?
|
| Lung Injury | 1 | 2023 | 57 | 0.200 |
Why?
|
| Binding Sites | 3 | 2015 | 1131 | 0.200 |
Why?
|
| Polyelectrolytes | 1 | 2021 | 6 | 0.190 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2021 | 56 | 0.190 |
Why?
|
| Transfection | 2 | 2015 | 901 | 0.190 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2025 | 402 | 0.180 |
Why?
|
| Lung | 3 | 2023 | 1337 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 206 | 0.180 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 88 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 272 | 0.170 |
Why?
|
| Vascular Stiffness | 2 | 2017 | 30 | 0.170 |
Why?
|
| Nanowires | 1 | 2020 | 6 | 0.170 |
Why?
|
| Molecular Imaging | 1 | 2021 | 70 | 0.170 |
Why?
|
| Silicon | 1 | 2020 | 19 | 0.170 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 260 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2021 | 86 | 0.160 |
Why?
|
| Myocardium | 2 | 2025 | 586 | 0.160 |
Why?
|
| Membrane Potentials | 3 | 2006 | 436 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 2396 | 0.160 |
Why?
|
| Fibroblasts | 2 | 2023 | 768 | 0.160 |
Why?
|
| Nanostructures | 1 | 2020 | 82 | 0.160 |
Why?
|
| Sepsis | 1 | 2023 | 351 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1724 | 0.150 |
Why?
|
| Myosin Light Chains | 2 | 2016 | 29 | 0.150 |
Why?
|
| Fibrillar Collagens | 1 | 2018 | 10 | 0.150 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2018 | 18 | 0.150 |
Why?
|
| Thioredoxins | 1 | 2018 | 13 | 0.150 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 29 | 0.140 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 198 | 0.140 |
Why?
|
| Glucose | 1 | 2021 | 683 | 0.140 |
Why?
|
| Vasodilation | 1 | 2018 | 91 | 0.140 |
Why?
|
| Veins | 1 | 2018 | 95 | 0.140 |
Why?
|
| CD36 Antigens | 1 | 2017 | 15 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 390 | 0.140 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 43 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 439 | 0.140 |
Why?
|
| Endothelin-1 | 1 | 2017 | 40 | 0.140 |
Why?
|
| Upper Extremity | 1 | 2018 | 62 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 129 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2018 | 51 | 0.140 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2018 | 70 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 60 | 0.140 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 96 | 0.130 |
Why?
|
| GTP Phosphohydrolases | 1 | 2017 | 75 | 0.130 |
Why?
|
| Ion Channels | 2 | 2010 | 251 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2017 | 107 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2017 | 133 | 0.130 |
Why?
|
| Protein Folding | 1 | 2018 | 291 | 0.120 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2015 | 14 | 0.120 |
Why?
|
| Chromatin | 1 | 2018 | 424 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 3375 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2018 | 340 | 0.120 |
Why?
|
| Alleles | 1 | 2018 | 1142 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 236 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2025 | 2097 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 48 | 0.110 |
Why?
|
| Male | 10 | 2025 | 43927 | 0.110 |
Why?
|
| Epinephrine | 2 | 2022 | 89 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 221 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 354 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2015 | 696 | 0.100 |
Why?
|
| Monocytes | 1 | 2014 | 223 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2449 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2038 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2015 | 1140 | 0.100 |
Why?
|
| Cytoskeleton | 2 | 2021 | 202 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2012 | 177 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2012 | 211 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2012 | 277 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 161 | 0.090 |
Why?
|
| Leukocytes | 1 | 2012 | 212 | 0.090 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2012 | 431 | 0.090 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2010 | 43 | 0.090 |
Why?
|
| Hemorheology | 1 | 2010 | 8 | 0.090 |
Why?
|
| I-kappa B Proteins | 1 | 2010 | 54 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 41 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2449 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2010 | 468 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2025 | 1607 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 250 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 358 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 562 | 0.080 |
Why?
|
| Membrane Microdomains | 2 | 2010 | 54 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 794 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 888 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 707 | 0.070 |
Why?
|
| Base Sequence | 1 | 2012 | 2319 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 696 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 998 | 0.070 |
Why?
|
| Heart Failure | 1 | 2018 | 1341 | 0.070 |
Why?
|
| Fibrosis | 2 | 2018 | 239 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 561 | 0.060 |
Why?
|
| Diet, Atherogenic | 1 | 2006 | 15 | 0.060 |
Why?
|
| Ion Channel Gating | 2 | 2010 | 331 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 5429 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 267 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2006 | 62 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2006 | 84 | 0.060 |
Why?
|
| Adrenergic Agonists | 1 | 2005 | 2 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 2505 | 0.060 |
Why?
|
| Hypokalemia | 1 | 2005 | 23 | 0.060 |
Why?
|
| Barium | 1 | 2005 | 31 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2006 | 684 | 0.060 |
Why?
|
| Rhabdomyolysis | 1 | 2005 | 28 | 0.060 |
Why?
|
| Medication Errors | 1 | 2005 | 39 | 0.060 |
Why?
|
| Tibet | 1 | 2025 | 21 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 397 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 242 | 0.060 |
Why?
|
| Altitude | 1 | 2025 | 47 | 0.060 |
Why?
|
| Stem Cells | 1 | 2007 | 382 | 0.060 |
Why?
|
| United States | 1 | 2017 | 7348 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 501 | 0.050 |
Why?
|
| Potassium | 1 | 2005 | 261 | 0.050 |
Why?
|
| Anoctamin-1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 12 | 0.050 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2023 | 45 | 0.050 |
Why?
|
| Muscle Development | 1 | 2023 | 42 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 87 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2006 | 507 | 0.050 |
Why?
|
| Chlorides | 1 | 2023 | 104 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2022 | 29 | 0.050 |
Why?
|
| Metallothionein | 1 | 2022 | 13 | 0.050 |
Why?
|
| Regeneration | 1 | 2023 | 157 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2010 | 1689 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 364 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 329 | 0.050 |
Why?
|
| Autopsy | 1 | 2021 | 123 | 0.040 |
Why?
|
| Pliability | 1 | 2020 | 5 | 0.040 |
Why?
|
| Neuropilin-1 | 1 | 2020 | 14 | 0.040 |
Why?
|
| Semaphorins | 1 | 2020 | 17 | 0.040 |
Why?
|
| Motion | 1 | 2020 | 94 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 80 | 0.040 |
Why?
|
| Integrins | 1 | 2020 | 79 | 0.040 |
Why?
|
| Models, Biological | 2 | 2021 | 1786 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 700 | 0.040 |
Why?
|
| Female | 6 | 2021 | 47893 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 291 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 843 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 589 | 0.040 |
Why?
|
| Tunica Media | 1 | 2018 | 16 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2018 | 4 | 0.040 |
Why?
|
| Neointima | 1 | 2018 | 14 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2018 | 62 | 0.040 |
Why?
|
| NADPH Oxidase 4 | 1 | 2018 | 15 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 111 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2017 | 38 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 568 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 801 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2017 | 21 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 49 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 402 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 410 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 76 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2017 | 114 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 280 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2016 | 19 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 265 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 161 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1847 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2014 | 34 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 109 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1232 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 295 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 827 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 131 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1901 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 1183 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1016 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 27538 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 488 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 601 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2075 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 4066 | 0.020 |
Why?
|
| Shear Strength | 1 | 2010 | 17 | 0.020 |
Why?
|
| Vasculitis | 1 | 2010 | 39 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2010 | 46 | 0.020 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2010 | 19 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3018 | 0.020 |
Why?
|
| TRPC Cation Channels | 1 | 2010 | 23 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2010 | 42 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2010 | 41 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2010 | 107 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 4471 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 208 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2010 | 130 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2010 | 125 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2010 | 182 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 259 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5706 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6920 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2010 | 464 | 0.020 |
Why?
|
| Micromanipulation | 1 | 2006 | 6 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2006 | 9 | 0.020 |
Why?
|
| Cell Size | 1 | 2006 | 71 | 0.020 |
Why?
|
| Elasticity | 1 | 2006 | 101 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 381 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2007 | 310 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2006 | 402 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2006 | 139 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2006 | 148 | 0.010 |
Why?
|
| Cricetulus | 1 | 2004 | 128 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 189 | 0.010 |
Why?
|
| Drug Overdose | 1 | 2005 | 78 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 538 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 19951 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2005 | 2506 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 27043 | 0.010 |
Why?
|